Antibiotic resistance & making medicines in Britain

The new Director of the Wellcome Trust, Jeremy Farrar is right to highlight the ticking bomb of antibiotic resistance and reminds us of the perils that we face if we continue to ignore this emerging public health issue (Britain is reaching 'a tipping point in its use of antibiotics', Jan 8). Part of the solution must inevitably involve greater working in partnership between commercial organisations such as biotech, pharmaceutical companies, charities, the NHS and central government.  But making new medicines is an expensive and risky business.